From Tim Anaya <[email protected]>
Subject What Cereal Can Teach Us About the Generic Drug Market
Date January 3, 2022 9:59 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])

What Cereal Can Teach Us About the Generic Drug Market

Washington Times | Sally C. Pipes
January 2, 2022

Imagine you’re walking the aisles of your local supermarket, on the hunt for your favorite cereal. You usually purchase the generic version, since it tastes nearly the same and is much cheaper than the name-brand version.

Read more. . . ([link removed])

The FDA Needs Reform. Biden's Nominee is Not the Person to Do It

Washington Examiner | Henry I. Miller, M.S., M.D. and Jeff Stier
December 29, 2021

. . . The FDA, a huge and critically important but dysfunctional organization, now needs a bold, clear-thinking reformer, but Califf, the ultimate insider, has the ideal resume to keep it on the wrong path.
Read more. . . ([link removed])

Expanding Telehealth Access is a Lifesaver for Vulnerable Patients

Palm Beach Post, Cincinnati Enquirer and Yahoo! News | Sally C. Pipes
December 29, 2021

It’s hard to find a silver lining in a pandemic. But COVID-19 has convinced the medical and policymaking establishments, perhaps unwittingly, that high-quality care can be delivered remotely. The telehealth revolution is upon us.
Read more. . . ([link removed])

Democrats Stumble Over Their Shady BBB Gimmicks

Newsmax | Sally C. Pipes
December 29, 2021

Last week, on Dec. 19 specifically, Sen. Joe Manchin, D-W.Va., announced ([link removed]) that he would not support the current iteration of the Build Back Better Act. His decision calls the future of the $1.75 trillion spending package into serious question. For this, Democrats have only themselves to blame.
Read more. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2022 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 | Pasadena, CA 91116

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis